CAJ | 학술논문

目的评价晚期肝癌肝移植的疗效.方法对作者近年完成的9例晚期肝癌肝移植进行回顾性分析.结果3例死于与肿瘤无关的并发症;其余6例中3例肝癌复发(2例死亡,1例带瘤生存),3例健康存活.肿瘤复发率50.0%(3/6),1年生存率66.7%(4/6),1年无瘤生存率50.0%(3/6).结论晚期肝癌不是肝移植的良好适应证,但可以有条件地开展,其中至少有一部分病人可获得一定时间的无瘤健康存活.
목적평개만기간암간이식적료효.방법대작자근년완성적9례만기간암간이식진행회고성분석.결과3례사우여종류무관적병발증;기여6례중3례간암복발(2례사망,1례대류생존),3례건강존활.종류복발솔50.0%(3/6),1년생존솔66.7%(4/6),1년무류생존솔50.0%(3/6).결론만기간암불시간이식적량호괄응증,단가이유조건지개전,기중지소유일부분병인가획득일정시간적무류건강존활.
Objective: To evaluate the effect of liver transplantation for end - stage hepatocarcinoma. Methods:9 cases of liver transplantation for end - stage hepatocarcinoma in recent years were reviewed. Results: 3 cases died of the complications without corrdation to tumor. In the rest 6 cases, there were 3 cases in which hepatocarcinoma recurred. 3 cases have healthily survived up to now. In all cases, recurrence rate of tumor was 50% ,one year survival rate was 66.7%. The year survival rate without tumor was 50%. Conclusions: Although the end - stage hepatocarcinoma is not a satisfactory indication for liver transplantation, it can be undergone properly in some cases.